Literature DB >> 851501

Fosfomycin in chronic urinary infections.

A Allona, J A Díaz Cabrera, P Manchado.   

Abstract

Fosfomycin has been used on 40 patients with serious urinary infections of different clinical nature, and produced by repetitive infection (prostatisms, carcinomas, lithiasis, hydronephrosis, etc.) The following were isolated in the urocultures: E. coli (60%), Klebsiella (15%), P. aeruginosa (15.0%), Proteus sp. (15.0%), Staphylococcus (5%), S. faecalis (2.5%) and Paracolobactrum coliforme (2.5%). All the germs isolated before treatment were sensitive to fosfomycin. The results, as regards response to the bacteriuria, were 71.4% eradication of the infection, 17.2% reinfections and 11.4% failures. The results are considered very satisfactory in view of the etiopathogenic nature of the processes under treatment.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 851501     DOI: 10.1159/000222059

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  6 in total

1.  Penetration of fosfomycin into cerebrospinal fluid across non-inflamed and inflamed meninges.

Authors:  E Kühnen; G Pfeifer; C Frenkel
Journal:  Infection       Date:  1987 Nov-Dec       Impact factor: 3.553

2.  In vitro and in vivo study of fosfomycin in methicillin-resistant Staphylococcus aureus septicaemia.

Authors:  W Y Lau; C H Teoh-Chan; S T Fan; K F Lau
Journal:  J Hyg (Lond)       Date:  1986-06

3.  In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.

Authors:  S H Guenthner; R P Wenzel
Journal:  Antimicrob Agents Chemother       Date:  1984-08       Impact factor: 5.191

4.  Disposition of phosphomycin in patients with pleural effusion.

Authors:  C F Lastra; E L Mariño; M Barrueco; M S Gervós; A D Gil
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

5.  Pharmacokinetics of fosmidomycin, a new phosphonic acid antibiotic.

Authors:  T Murakawa; H Sakamoto; S Fukada; T Konishi; M Nishida
Journal:  Antimicrob Agents Chemother       Date:  1982-02       Impact factor: 5.191

6.  Fosfomycin enhances phagocyte-mediated killing of Staphylococcus aureus by extracellular traps and reactive oxygen species.

Authors:  Fengge Shen; Xudong Tang; Wei Cheng; Yang Wang; Chao Wang; Xiaochen Shi; Yanan An; Qiaoli Zhang; Mingyuan Liu; Bo Liu; Lu Yu
Journal:  Sci Rep       Date:  2016-01-18       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.